Market Insights Health Pharmacies OTC Products

Analgesics (Pharmacies) - France

France

Revenue in the Analgesics market is projected to reach €0.63bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 4.11%, resulting in a market volume of €0.74bn by 2028.
In global comparison, most revenue will be generated in China (€4,663.00m in 2024).
In relation to total population figures, per person revenues of €9.74 are generated in 2024.

Key regions: Europe, United States, Canada, India, South Korea

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Analgesics (Pharmacies) market in France has been experiencing steady growth in recent years.

Customer preferences: French consumers have shown a growing preference for analgesics purchased from pharmacies rather than other retail channels. This preference can be attributed to the trust and reliability associated with pharmacy products, as well as the availability of knowledgeable pharmacists who can provide advice and recommendations. Additionally, the convenience of purchasing analgesics alongside other healthcare products in one location is appealing to consumers.

Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in France is the increasing demand for over-the-counter (OTC) analgesics. This trend can be attributed to several factors. Firstly, the aging population in France is driving the need for pain relief solutions, as older individuals are more prone to chronic pain conditions. Secondly, the rising awareness of self-care and the importance of managing minor aches and pains at home has led to an increased demand for OTC analgesics. Lastly, the COVID-19 pandemic has further accelerated the demand for OTC analgesics, as more individuals are seeking relief from symptoms such as headaches and body aches associated with the virus.

Local special circumstances: France has a well-established healthcare system, which includes a network of pharmacies that play a crucial role in providing healthcare services to the population. Pharmacies in France are highly regulated and are required to have a licensed pharmacist present at all times. This regulatory framework ensures the quality and safety of analgesics sold in pharmacies, further enhancing consumer trust in these products. Additionally, the French government has implemented policies to promote the use of generic analgesics, which has contributed to the affordability and accessibility of these products.

Underlying macroeconomic factors: The steady growth of the Analgesics (Pharmacies) market in France can be attributed to several underlying macroeconomic factors. Firstly, the increasing disposable income of the French population has allowed for greater spending on healthcare products, including analgesics. Secondly, the growing focus on health and wellness in French society has led to a greater emphasis on self-care and preventive healthcare, driving the demand for analgesics. Lastly, the aging population in France, coupled with the high prevalence of chronic pain conditions, has created a sustained demand for analgesics. In conclusion, the Analgesics (Pharmacies) market in France is experiencing steady growth due to customer preferences for pharmacy products, the increasing demand for OTC analgesics, the well-established healthcare system in France, and underlying macroeconomic factors such as increasing disposable income and an aging population.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.